Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
216.15
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Jan 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
216.15
Bid (Size)
215.08 (500)
Ask (Size)
217.00 (100)
Prev. Close
216.15
Today's Range
216.15 - 216.15
52wk Range
164.39 - 244.81
Shares Outstanding
N/A
Dividend Yield
3.03%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Titan’s Balance: Johnson & Johnson Reaches Record Highs Amidst Legal Hurdles and Med-Tech Transformation
January 20, 2026
As the healthcare industry looks toward 2026, Johnson & Johnson (NYSE: JNJ) stands at a historic crossroads, reinforcing its reputation as the ultimate bellwether for the global healthcare sector. On...
Via
MarketMinute
Topics
Bankruptcy
Lawsuit
World Trade
1 Safe-and-Steady Stock on Our Watchlist and 2 We Find Risky
January 19, 2026
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Via
StockStory
Performance
YTD
-5.7%
-5.7%
1 Month
-5.2%
-5.2%
3 Month
-5.5%
-5.5%
6 Month
+13.4%
+13.4%
1 Year
+25.2%
+25.2%
More News
Read More
The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever
↗
January 19, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
AbbVie Seeks To Grow Obesity Drug Portfolio — Retail Touts Drugmaker As Big Competition To Lilly
↗
January 14, 2026
Via
Stocktwits
3 “Forever Stocks” to Hold When the Market Won’t Sit Still
↗
January 19, 2026
Via
MarketBeat
The New Era of Johnson & Johnson: A 2026 Deep-Dive Research Feature
January 19, 2026
Via
Finterra
Topics
Artificial Intelligence
Bankruptcy
Economy
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
↗
January 19, 2026
Via
The Motley Fool
Topics
Intellectual Property
The Smartest Dividend Stocks to Buy in 2026 With $1,000 Right Now -- Including Realty Income and AbbVie
↗
January 19, 2026
Via
The Motley Fool
Could Buying This Stock Today Pay Off Big Over the Next 5 Years?
↗
January 18, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie Call Options Spike 2,599%: Tracking the Big Bet
↗
January 16, 2026
Via
MarketBeat
Genmab Reports Mixed Results From Late-Stage Trial Of Lymphoma Drug
↗
January 16, 2026
Via
Stocktwits
3 Absurdly Cheap Growth Stocks to Buy in 2026
↗
January 15, 2026
Via
The Motley Fool
Healthcare Titan Ascendant: Johnson & Johnson Hits All-Time Highs as It Navigates a New Political and Clinical Era
January 15, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bankruptcy
Earnings
Nasdaq, S&P 500 Futures Edge Lower Ahead Of CPI, JPMorgan Earnings: Why MSFT, NVDA, ABBV, ABAT Are Also On Traders' Radar Today
↗
January 13, 2026
Via
Stocktwits
Topics
Artificial Intelligence
Credit Cards
ETFs
Revolution Medicines Dismisses Merck, Abbvie Buyout Talks While Analyst Say It Is Worth More Than $32B
↗
January 12, 2026
Via
Stocktwits
The AI-Bio Convergence: Lilly and Nvidia Kick Off JPM26 with Landmark $1 Billion Alliance
January 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Intellectual Property
3 No-Brainer Dividend Stocks to Buy Right Now
↗
January 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
This ETF Is Proof That the Healthcare Rebound Is Real
↗
January 11, 2026
Via
MarketBeat
Topics
ETFs
Eli Lilly Solidifies Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences
January 09, 2026
Via
MarketMinute
2 Healthcare Stocks That Can Diversify a Tech-Heavy Portfolio
↗
January 09, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
Lawsuit
MoonLake Immunotherapeutics Surges as FDA "De-Risks" Sonelokimab, Reigniting Multi-Billion Dollar Takeover Speculation
January 09, 2026
Via
MarketMinute
Topics
Intellectual Property
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
January 08, 2026
Via
MarketMinute
Topics
Intellectual Property
1 Unpopular Stock That Deserves a Second Chance and 2 We Question
January 07, 2026
Via
StockStory
Ironwood Pharmaceuticals’ 2026 Guidance Shock Sparks a Major Re-Rating
↗
January 07, 2026
Via
MarketBeat
Revolution Medicines Stock Soars On Report Of AbbVie Takeover
↗
January 07, 2026
Via
Stocktwits
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 216.15
When was AbbVie last traded?
The last trade of AbbVie was at 01/21/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.